Door closes on drug discovery. IBM is tapering off sales of its Watson for Drug Discovery product in favor of other healthcare offerings using the AI technology, STAT reported this morning. The decision was made in response to weak demand and purchases from customers.
"We are focusing our resources within Watson Health to double down on the adjacent field of clinical development where we see an...
Yesterday PathAI, a Boston-based maker of artificial intelligence tools for pathology, closed a $60 million Series B funding round led by General Atlantic. Other existing investors, most notably General Catalyst, also participated in the round.
To monitor its investment, General Atlantic Managing Director Dr. Michelle Dipp will also be joining the AI company’s board of directors.
WHAT THEY DO...
Aidoc, an Israel-based provider of AI solutions for radiologists, announced that it has raised $27M, bringing its total funding to $40M. The Series B round, led by Square Peg Capital, will be used to grow Aidoc's technology and go-to-market team to support the high market demand for its products.
The funding comes as Aidoc announced that it has analysed its millionth patients CT scan in real-time...
VR cardiac care training. Healthcare training and education firm Health Scholars has launched a VR training simulation to help clinicians practice their advanced cardiac life support (ACLS) skills. The app was built to follow the American Heart Association’s guidelines and programs and incorporates a voice recognition component.
“Our mission is to improve patient safety, and by virtualizing ACLS...
The stakes are high when it comes to implementing artificial intelligence in healthcare, Massachusetts Governor Charlie Baker reminded the audience at the World Medical Innovation Forum in Boston yesterday.
While the technology has the ability to shape the future of health, Baker — who previously served as the CEO of Harvard Pilgrim Health Care — urged the industry to be mindful about data...
Deep Lens, a digital pathology startup particularly focused on cancer trials, has brought in a $13.65 million Series A round, according to an SEC filing. The fundraise was headed by Northpond Ventures with additional support from prior investors Rev1 Ventures, Sierra Ventures and Tamarind-Hill Partners, according to a release.
The Series A comes quickly after a seed funding round that raised just...
FDA Commissioner Dr. Scott Gottlieb may be stepping down, but he isn’t slowing down on his way out the door. Yesterday the agency dropped a 20-page exploratory whitepaper on how it could address artificial intelligence and machine learning algorithms.
“As algorithms evolve, the FDA must also modernize our approach to regulating these products,” Gottlieb wrote in a statement. “We must ensure that...
At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off stage about the work the top Israeli pharma company has been doing in digital health. These topics included the company's recently FDA-cleared smart inhaler ProAir Digihaler, as well as more broad...
Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal signed by the pharmaceutical company and Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses.
According to the announcement, Concerto’s eurekaHealth tool will “accelerate insights through novel health economic...
As more big names in tech are jumping into the healthcare arena, the industry is getting a makeover. Now Nvidia, a hardware company best known for creating consumer and professional-grade graphics processing units (GPUs) as well as chip units for mobile computing, sees an opportunity to carve out a bigger name for itself in the space.
“I think that computational biology is the future,” Kimberly...
